Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05480644

Enrollment

300

Registered

2022-07-29

Start date

2022-12-01

Completion date

2032-12-31

Last updated

2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Metastases, Adult, Brain Tumor, Primary

Brief summary

The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.

Detailed description

Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Number of circulating immune cells in peripheral blood	6 weeks post radiation therapy	reported as mean +/- standard deviation

Countries

United States

Contacts

Primary ContactKaitlin Bailey, RN OCN

Kaitlin.Bailey@duke.edu(919) 668-3726

Backup ContactLinda Kaltenbach, PhD

Linda.Kaltenbach@duke.edu

Outcome results